Advertisement
Advertisement

CTKB

CTKB logo

Cytek Biosciences, Inc. Common Stock

5.00
USD
Sponsored
-0.01
-0.22%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

5.00

0.00
-0.08%

CTKB Earnings Reports

Positive Surprise Ratio

CTKB beat 10 of 18 last estimates.

56%

Next Report

Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$45.28M
/
-$0.09
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
+9.23%
/
--

Cytek Biosciences, Inc. Common Stock earnings per share and revenue

On Jan 28, 2026, CTKB reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.04 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 58.33 million, with a --% difference. The market reacted with a -3.91% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 7 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 45.28 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q4 2025, Cytek Biosciences, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved down -3.91%, changed from $5.62 before the earnings release to $5.40 the day after.
The next earning report is scheduled for May 06, 2026.
Based on 7 analysts, Cytek Biosciences, Inc. Common Stock is expected to report EPS of -$0.09 and revenue of $45.28M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement